Under construction – not a live service
Sign in
Not yet taking people in United StatesNo phase

Compares heart effects of cigarettes and e-cigarettes in older adults with high blood pressure

Compares heart effects of cigarettes and e-cigarettes in older adults with hypertension.

Plain-language title generated from the registry record
Registry title: Cardiovascular Impacts of E-cigarettes Among Older Adults

Key facts

Where
Baltimore, United StatesSee the site

Where in United States

  • Kahlert Institute for Addiction MedicineBaltimore, United StatesNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University of Maryland, Baltimore
Trial code
NCT07880704
Record updated
19 October 2026
Original description
This study will compare the cardiovascular effects of continued smoking with those of e-cigarette (EC) use among older adults with hypertension. Using both laboratory and real-world measurements, this study will be the first to examine the relative cardiovascular impacts of smoking and EC in a patient population at high risk of smoking-related disease progression.Read full original descriptionShow less

Comparison of Cigarette Smoking and E-cigarette Use

This study will compare the cardiovascular effects of continued smoking with those of e-cigarette (EC) use among older adults with hypertension. Using both laboratory and real-world measurements, this study will be the first to examine the relative cardiovascular impacts of smoking and EC in a patient population at high risk of smoking-related disease progression.

Inclusion: Age 50 years or older; Currently smokes 5 or more combustible tobacco cigarettes per day and has smoked at this level for at least 1 year, based on self-report; Expired-air carbon monoxide level ≥8 parts per million (ppm), confirming recent cigarette smoking; Average screening/baseline systolic blood pressure ≥130 mm Hg or average screening diastolic blood pressure ≥80 mm Hg; Able and willing to provide informed consent and complete the study procedures, including in-person visits, two 14-day study periods, daily check-ins, and use of study equipment; If able to become pregnant (confirmed with participant), agree to avoid pregnancy during the study.

Exclusion: Currently seeking or receiving smoking-cessation treatment; Currently taking medication for the treatment of hypertension; Experienced a major medical event, including a cardiovascular event, within the past 6 months, such as myocardial infarction or acute coronary syndrome, stroke or transient ischemic attack, coronary or peripheral revascularization, hospitalization for heart failure; A current unstable cardiovascular condition that, in the judgment of the PI or designated medical clinician, would make participation unsafe; Confirmed severe hypertension at screening: resting systolic blood pressure greater than 180 mm Hg OR diastolic blood pressure greater than 120 mm Hg on repeat assessment; The investigator or medical monitor determines that participation would present an unacceptable medical or safety risk (i.e., current concerning cardiovascular or neurologic symptoms; an acute or uncontrolled medical illness; clinically significant intoxication or withdrawal; a medication or health change likely to make blood pressure, heart rate, or study participation unsafe; inability to safely use the study equipment despite training; or another specific condition that creates a foreseeable risk from continued smoking, e-cigarette exposure, or study procedures); Self-reported consumption of 4 or more standard alcoholic drinks for women or 5 or more for men on any single day during the past 30 days; Self-reported daily nonmedical use of opioids, stimulants, sedatives, cannabis, or another substance; Currently uses another tobacco or nicotine product (e.g., electronic cigarettes or smokeless tobacco) on 2 or more consecutive days during the past month; Pregnancy, as indicated by a positive screening urine pregnancy test conducted for a participant who reports being able to become pregnant.

ClinicalTrials.gov NCT07880704